Bioinformatics Network Analyses of Growth Differentiation Factor 11

Overview

Journal Open Life Sci

Specialty Biology

Date 2022 May 18

PMID 35582621

Authors

Feng Zhang

Xia Yang

Zhijun Bao

Affiliations

Soon will be listed here.

Abstract

Growth differentiation factor 11 (GDF11) has been implicated in rejuvenating functions in age-related diseases. The molecular mechanisms connecting GDF11 with these anti-aging phenomena, including reverse age-related cardiac hypertrophy and vascular and neurogenic rejuvenation, remain unclear. In this study, we sought to uncover the molecular functions of GDF11 using bioinformatics and network-driven analyses at the human gene and transcription levels using the gene co-expression network analysis, the protein-protein interaction network analysis, and the transcription factor network analysis. Our findings suggested that GDF11 is involved in a variety of functions, such as apoptosis, DNA repair, telomere maintenance, and interaction with key transcription factors, such as MYC proto-oncogene, specificity protein 1, and ETS proto-oncogene 2. The human skin fibroblast premature senescence model was established by UVB. The treatment with 10 ng/mL GDF11 in this cell model could reduce cell damage, reduce the apoptosis rate and the expression of caspase-3, and increase the length of telomeres. Therefore, our findings shed light on the functions of GDF11 and provide insights into the roles of GDF11 in aging.

References

Zhang J, Li Y, Li H, Zhu B, Wang L, Guo B . GDF11 Improves Angiogenic Function of EPCs in Diabetic Limb Ischemia. Diabetes. 2018; 67(10):2084-2095. DOI: 10.2337/db17-1583. View

Roy S, Bhattacharyya D, Kalita J . Reconstruction of gene co-expression network from microarray data using local expression patterns. BMC Bioinformatics. 2014; 15 Suppl 7:S10. PMC: 4110735. DOI: 10.1186/1471-2105-15-S7-S10. View

Pan F, Brissova M, Powers A, Pfaff S, Wright C . Inactivating the permanent neonatal diabetes gene Mnx1 switches insulin-producing β-cells to a δ-like fate and reveals a facultative proliferative capacity in aged β-cells. Development. 2015; 142(21):3637-48. PMC: 4647212. DOI: 10.1242/dev.126011. View

Jaskelioff M, Muller F, Paik J, Thomas E, Jiang S, Adams A . Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature. 2010; 469(7328):102-6. PMC: 3057569. DOI: 10.1038/nature09603. View

Presnell J, Schnitzler C, Browne W . KLF/SP Transcription Factor Family Evolution: Expansion, Diversification, and Innovation in Eukaryotes. Genome Biol Evol. 2015; 7(8):2289-309. PMC: 4558859. DOI: 10.1093/gbe/evv141. View

Beishline K, Kelly C, Olofsson B, Koduri S, Emrich J, Greenberg R . Sp1 facilitates DNA double-strand break repair through a nontranscriptional mechanism. Mol Cell Biol. 2012; 32(18):3790-9. PMC: 3430196. DOI: 10.1128/MCB.00049-12. View

Marbach D, Lamparter D, Quon G, Kellis M, Kutalik Z, Bergmann S . Tissue-specific regulatory circuits reveal variable modular perturbations across complex diseases. Nat Methods. 2016; 13(4):366-70. PMC: 4967716. DOI: 10.1038/nmeth.3799. View

Zhang Y, Shao J, Wang Z, Yang T, Liu S, Liu Y . Growth differentiation factor 11 is a protective factor for osteoblastogenesis by targeting PPARgamma. Gene. 2014; 557(2):209-14. DOI: 10.1016/j.gene.2014.12.039. View

Koh C, Khattar E, Leow S, Liu C, Muller J, Ang W . Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity. J Clin Invest. 2015; 125(5):2109-22. PMC: 4463203. DOI: 10.1172/JCI79134. View

10.

Zhang Y, Chen L, Yang S, Fang D . E2F1: a potential negative regulator of hTERT transcription in normal cells upon activation of oncogenic c-Myc. Med Sci Monit. 2011; 18(1):RA12-15. PMC: 3560676. DOI: 10.12659/msm.882192. View

11.

Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M . Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res. 2000; 28(3):669-77. PMC: 102554. DOI: 10.1093/nar/28.3.669. View

12.

Khattar E, Tergaonkar V . Transcriptional Regulation of Telomerase Reverse Transcriptase (TERT) by MYC. Front Cell Dev Biol. 2017; 5:1. PMC: 5266692. DOI: 10.3389/fcell.2017.00001. View

13.

Lim E, Xu H, Wu P, Posner D, Wu J, Peloso G . Network analysis of drug effect on triglyceride-associated DNA methylation. BMC Proc. 2018; 12(Suppl 9):27. PMC: 6157190. DOI: 10.1186/s12919-018-0130-0. View

14.

Schuijers J, Manteiga J, Weintraub A, Day D, Zamudio A, Hnisz D . Transcriptional Dysregulation of MYC Reveals Common Enhancer-Docking Mechanism. Cell Rep. 2018; 23(2):349-360. PMC: 5929158. DOI: 10.1016/j.celrep.2018.03.056. View

15.

Malinauskas T, Aricescu A, Lu W, Siebold C, Jones E . Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1. Nat Struct Mol Biol. 2011; 18(8):886-93. PMC: 3430870. DOI: 10.1038/nsmb.2081. View

16.

Pusceddu I, Farrell C, Di Pierro A, Jani E, Herrmann W, Herrmann M . The role of telomeres and vitamin D in cellular aging and age-related diseases. Clin Chem Lab Med. 2015; 53(11):1661-78. DOI: 10.1515/cclm-2014-1184. View

17.

Gaunt S . Gdf11/Smad signalling and Cdx proteins cooperate to activate the Hoxc8 early enhancer in HepG2 cells. Int J Dev Biol. 2017; 61(6-7):427-432. DOI: 10.1387/ijdb.170066sg. View

18.

Xiao A, Zhang Y, Ren Y, Chen R, Li T, You C . GDF11 alleviates secondary brain injury after intracerebral hemorrhage via attenuating mitochondrial dynamic abnormality and dysfunction. Sci Rep. 2021; 11(1):3974. PMC: 7889617. DOI: 10.1038/s41598-021-83545-x. View

19.

Mei W, Zhu B, Shu Y, Liang Y, Lin M, He M . GDF11 protects against glucotoxicity-induced mice retinal microvascular endothelial cell dysfunction and diabetic retinopathy disease. Mol Cell Endocrinol. 2021; 537:111422. DOI: 10.1016/j.mce.2021.111422. View

20.

Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J . STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2014; 43(Database issue):D447-52. PMC: 4383874. DOI: 10.1093/nar/gku1003. View